EFFICACY AND TOLERABILITY OF TIP (PACLITAXEL, IFOSFAMIDE AND CISPLATIN) INCORPORATED INTO INDUCTION CHEMOTHERAPY FOR PATIENTS WITH INTERMEDIATE- OR POOR-RISK METASTATIC GERM CELL TUMORS

被引：0
|
作者：
Nishikawa, Masatomo
Miyake, Hideaki
Fujisawa, Masato
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
10.1016/j.juro.2015.02.415
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP10-14
引用
收藏
页码：E116 / E116
页数：1
相关论文
共 50 条
  • [41] Comparison of standard versus high dose of paclitaxel with ifosfamide and cisplatin (TIP) in salvage therapy of germ cell tumors (GCTs).
    Mardiak, Jozef
    Mego, Michal
    Miskovska, Viera
    Sycova-Mila, Zuzana
    Obertova, Jana
    Palacka, Patrik
    Usakova, Vanda
    Rajec, Jan
    Liskova, Stefania
    Vertakova-Krakovska, Bibiana
    Chovanec, Michal
    Salek, Tomas
    Reckova, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour
    Shayegan, Bobby
    Carver, Brett S.
    Stasi, Jason
    Motzer, Robert J.
    Bosl, George J.
    Sheinfeld, Joel
    BJU INTERNATIONAL, 2007, 99 (05) : 993 - 997
  • [43] High-dose chemotherapy with autologous stem cell support in poor-risk germ cell tumors
    W. Siegert
    O. Rick
    J. Beyer
    Annals of Hematology, 1998, 76 : 183 - 188
  • [44] High-dose chemotherapy with autologous stem cell support in poor-risk germ cell tumors
    Siegert, W
    Rick, O
    Beyer, J
    ANNALS OF HEMATOLOGY, 1998, 76 (05) : 183 - 188
  • [45] Randomized trial comparing Bleomycin/Etoposide/Cisplatin with alternating Cisplatin/Cyclophosphamide/Doxorubicin and Vinblastine/Bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors:: Genito-urinary group of the french federation of cancer Centers trial T93MP
    Culine, Stephane
    Kramar, Andrew
    Theodore, Christine
    Geoffrois, Lionel
    Chevreau, Christine
    Biron, Pierre
    Nguyen, Binh Bui
    Heron, Jean-Francois
    Kerbrat, Pierre
    Caty, Armelle
    Delva, Remy
    Fargeot, Pierre
    Fizazi, Karim
    Bouzy, Jeannine
    Droz, Jean-Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) : 421 - 427
  • [46] ETOPOSIDE, CISPLATIN, BLEOMYCIN, AND CYCLOPHOSPHAMIDE (ECBC) AS 1ST-LINE CHEMOTHERAPY FOR POOR-RISK NONSEMINOMATOUS GERM-CELL TUMORS
    GERL, A
    CLEMM, C
    HENTRICH, M
    HARTENSTEIN, R
    WILMANNS, W
    ACTA ONCOLOGICA, 1993, 32 (05) : 541 - 546
  • [47] Factors Associated With Choriocarcinoma Syndrome Development in Poor-Risk Patients With Germ Cell Tumors
    Rejlekova, Katarina
    Kalavska, Katarina
    Makovnik, Marek
    Hapakova, Nikola
    Chovanec, Michal
    De Angelis, Valentina
    Obertova, Jana
    Palacka, Patrik
    Sycova-Mila, Zuzana
    Mardiak, Jozef
    Mego, Michal
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small-cell lung cancer
    Pohl, G
    Krajnik, G
    Malayeri, R
    Doweik, L
    Müller, RM
    Klepetko, W
    Eckersberger, F
    Schäfer-Prokop, C
    Schmeikal, S
    Smolle-Jüttner, FM
    Maier, A
    Ambrosch, G
    Minar, W
    Pirker, R
    Woltsche, M
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 416 - 416
  • [49] Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer
    Pohl, G
    Krajnik, G
    Malayeri, R
    Doweik, L
    Müller, RM
    Klepetko, W
    Eckersberger, F
    Schäffer-Prokop, C
    Schmeikal, S
    Smolle-Jüttner, FM
    Maier, A
    Ambrosch, G
    Woltsche, M
    Minar, W
    Pirker, R
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 237 - 244
  • [50] Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors
    Mardiak, J
    Fuchsberger, P
    Lakota, J
    Sálek, T
    Sycová-Milá, Z
    Drahokoupilová, M
    Baláz, M
    Koza, I
    NEOPLASMA, 2000, 47 (04) : 239 - 243
12345